12:00 AM
Mar 29, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Multikine: Began Phase II testing

(Results, B9)

Cel-Sci Corp. (HIV; Berlin:LSR), Vienna, Va.
Product: Multikine
Business: Cancer
Therapeutic category: Immune stimulation

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >